SAFECODE DRUG TECHNOLOGIES CORP. (CIK: 0001508470) EDGAR, Information, Filings... CompaniesBIO.Com

SAFECODE DRUG TECHNOLOGIES CORP.

Mailing address
6 MAEVER HAMILTAH STREET, JERUSALEM, Delaware, 97761
Phone
97225021322
State location
Israel
State of incorporation
Delaware
Fiscal year end
December 31
SIC
3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Filings
N/A

SAFECODE DRUG TECHNOLOGIES CORP. (CIK: 0001508470) is an American company incorporated in the state of Israel. Head office is located at 6 MAEVER HAMILTAH STREET, JERUSALEM, Israel, 97761. Work in the industry 3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS. SAFECODE DRUG TECHNOLOGIES CORP. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SAFECODE DRUG TECHNOLOGIES CORP.

Filings	Format	Description	Filed/Effective	File/Film Number
REVOKED	Document	Acc-no: 9999999997-16-027212 (34 Act) Size: 323 KB	Nov-29-2016	000-54656 162024120
UPLOAD	Document	Acc-no: 0000000000-14-003456 ( Act) Size: 38 KB	Jan-23-2014
UPLOAD	Document	Acc-no: 0000000000-14-000598 ( Act) Size: 128 KB	Jan-06-2014
UPLOAD	Document	Acc-no: 0000000000-13-064694 ( Act) Size: 153 KB	Nov-25-2013
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001558891-13-000165 (34 Act) Size: 2974 KB	Aug-13-2013	000-54656 131032266
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-13-027665 (34 Act) Size: 2078 KB	May-10-2013	000-54656 13831048
8-K	Document	Current report filing Acc-no: 0001144204-13-020511 (34 Act) Size: 14 KB	Apr-08-2013	000-54656 13747480
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-13-017087 (34 Act) Size: 1990 KB	Mar-25-2013	000-54656 13712649
8-K	Document	Current report filing Acc-no: 0001144204-13-014129 (34 Act) Size: 14 KB	Mar-11-2013	000-54656 13679545
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-068331 (34 Act) Size: 1378 KB	Dec-18-2012	000-54656 121269959
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-068328 (34 Act) Size: 1396 KB	Dec-18-2012	000-54656 121269958
8-K	Document	Current report filing Acc-no: 0001144204-12-064040 (34 Act) Size: 47 KB	Nov-20-2012	000-54656 121216432
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-060583 (34 Act) Size: 1372 KB	Nov-09-2012	000-54656 121191626
8-K	Document	Current report filing Acc-no: 0001144204-12-041859 (34 Act) Size: 31 KB	Jul-31-2012	000-54656 12995649
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-041634 (34 Act) Size: 1389 KB	Jul-30-2012	000-54656 12993332
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-028867 (34 Act) Size: 997 KB	May-15-2012	000-54656 12840859
8-A12G	Document	Form for registration of a class of securities pursuant to section 12(g) Acc-no: 0001144204-12-022112 (34 Act) Size: 19 KB	Apr-17-2012	000-54656 12762580
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-12-021146 (34 Act) Size: 310 KB	Apr-12-2012	333-174167 12755490
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-12-017866 (34 Act) Size: 1106 KB	Mar-29-2012	333-174167 12722210
EFFECT	Document	Acc-no: 9999999995-11-003633 (33 Act) Size: 1 KB	Dec-27-2011	333-174167 111282906

Recent 20 filings. View all SAFECODE DRUG TECHNOLOGIES CORP. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

SAFECODE DRUG TECHNOLOGIES CORP. overview
SAFECODE DRUG TECHNOLOGIES CORP. job
SAFECODE DRUG TECHNOLOGIES CORP. stock
SAFECODE DRUG TECHNOLOGIES CORP. ownership
SAFECODE DRUG TECHNOLOGIES CORP. CEO
SAFECODE DRUG TECHNOLOGIES CORP. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.